| Dr Robert Browning Edwards Ii, DC | |
|
685 Metacom Ave, Bristol, RI 02809-5131 | |
| (401) 396-9892 | |
| (401) 396-9897 |
| Full Name | Dr Robert Browning Edwards Ii |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 9 Years |
| Location | 685 Metacom Ave, Bristol, Rhode Island |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346617917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | DCP00641 (Rhode Island) | Primary |
| Provider Name | Apponaug Chiropractic Center Incorporated |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750581773 PECOS PAC ID: 0345135521 Enrollment ID: O20040217000595 |
News Archive
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection.
Writing in the Council on Foreign Relations' (CFR) "Development Channel" blog, Yanzhong Huang, a senior fellow for global health at CFR, reports on a workshop on the post-2015 development agenda.
Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.
As the world struggles to contain the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for over 1.6 million deaths and 76 million infections globally, researchers are trying to pin down the determinants of lethality, of infectivity and of protection. Such data would help contain its spread and develop preventive and therapeutic antivirals and vaccines. A new preprint that appeared recently on the bioRxiv* server describes the high degree of protection afforded by antibodies that target the N-terminal domain (NTD) of the virus.
› Verified 6 days ago
| Provider Name | Edwards Health Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326555277 PECOS PAC ID: 2163782913 Enrollment ID: O20180216000284 |
News Archive
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection.
Writing in the Council on Foreign Relations' (CFR) "Development Channel" blog, Yanzhong Huang, a senior fellow for global health at CFR, reports on a workshop on the post-2015 development agenda.
Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.
As the world struggles to contain the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for over 1.6 million deaths and 76 million infections globally, researchers are trying to pin down the determinants of lethality, of infectivity and of protection. Such data would help contain its spread and develop preventive and therapeutic antivirals and vaccines. A new preprint that appeared recently on the bioRxiv* server describes the high degree of protection afforded by antibodies that target the N-terminal domain (NTD) of the virus.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Browning Edwards Ii, DC 685 Metacom Ave, Bristol, RI 02809-5131 Ph: (401) 396-9892 | Dr Robert Browning Edwards Ii, DC 685 Metacom Ave, Bristol, RI 02809-5131 Ph: (401) 396-9892 |
News Archive
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection.
Writing in the Council on Foreign Relations' (CFR) "Development Channel" blog, Yanzhong Huang, a senior fellow for global health at CFR, reports on a workshop on the post-2015 development agenda.
Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.
As the world struggles to contain the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for over 1.6 million deaths and 76 million infections globally, researchers are trying to pin down the determinants of lethality, of infectivity and of protection. Such data would help contain its spread and develop preventive and therapeutic antivirals and vaccines. A new preprint that appeared recently on the bioRxiv* server describes the high degree of protection afforded by antibodies that target the N-terminal domain (NTD) of the virus.
› Verified 6 days ago
Dr. Aaron M Hoffmann, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 450 Hope St, 2nd Floor, Bristol, RI 02809 Phone: 401-253-1130 Fax: 401-253-8320 | |
Dr. Mark V Alano, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 576 Metacom Ave, Unit 8, Bristol, RI 02809 Phone: 401-253-1130 Fax: 401-253-8320 | |
Bristol Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 685 Metacom Ave, Bristol, RI 02809 Phone: 401-396-9892 Fax: 401-396-9897 | |
Martin L. Roussel, D.c. Dba East Bay Chiropractic Health Center Chiropractor Medicare: Medicare Enrolled Practice Location: 970 Hope St, Bristol, RI 02809 Phone: 401-253-7475 Fax: 401-253-8927 | |
Dr. David Michael Sequino, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 576 Metacom Ave. #3, Bristol, RI 02809 Phone: 401-254-7442 Fax: 401-254-7443 | |
Coastal Chiropractic Group Chiropractor Medicare: Medicare Enrolled Practice Location: 450 Hope St, 2nd Fl, Bristol, RI 02809 Phone: 401-253-1130 Fax: 401-253-8320 | |
Bristol Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 685 Metacom Ave, Bristol, RI 02809 Phone: 401-396-9892 Fax: 401-396-9897 |